Mitigating Emergency Drug Shortages Act
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Mitigating Emergency Drug Shortages Act
This bill requires the Food and Drug Administration (FDA) to prioritize the review of life-saving or life-sustaining drugs that are facing shortages. The bill also requires manufacturers to report certain information to the FDA when there is a permanent discontinuance or interruption in the manufacture of active pharmaceutical ingredients for such drugs.
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S6245-6246)
- Introduced in Senate Formatted Text PDF Formatted XML
Cite this page
U.S. Congress. (2026). S. 2723: Mitigating Emergency Drug Shortages Act. 116th Congress. Open America. https://openamerica.io/bill/116-S-2723/
"S. 2723: Mitigating Emergency Drug Shortages Act." 116th Congress, 2026, Open America, https://openamerica.io/bill/116-S-2723/.
S. 2723, 116th Cong. (2026), https://openamerica.io/bill/116-S-2723/.
[S. 2723: Mitigating Emergency Drug Shortages Act](https://openamerica.io/bill/116-S-2723/)